Navigating adalimumab biosimilars: an expert opinion

The patent expiry of Humira in 2018 opened up the current European market to eight adalimumab biosimilars - (in alphabetical order) Amgevita, Amsparity, Hulio, Hukyndra, Hyrimoz, Idacio, Imraldi and Yuflyma - for the treatment of various immune and inflammatory conditions. Amjevita, Hadlima, Hyrimoz...

Full description

Saved in:
Bibliographic Details
Main Authors: Vered Abitbol (Author), Salim Benkhalifa (Author), Caroline Habauzit (Author), Hubert Marotte (Author)
Format: Book
Published: Becaris Publishing Limited, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available